U.S. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

U.S. Transthyretin Amyloidosis Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR-CM) and Wild Type Amyloidosis), By Drug Type (Tafamidis, Diflunisal, Inotersen, Patisiran, Tolcapone, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

Published In: 03 Apr, 2026
Code: CMI1919
Page number: 116
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - U.S. Transthyretin Amyloidosis Treatment Market, By Type
  - U.S. Transthyretin Amyloidosis Treatment Market, By Drug Type
  - U.S. Transthyretin Amyloidosis Treatment Market, By Distribution Channel
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Epidemiology
U.S. Transthyretin Amyloidosis Treatment Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hereditary Transthyretin Amyloidosis (hATTR-CM)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Wild Type Amyloidosis (wATTR-CM)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
U.S. Transthyretin Amyloidosis Treatment Market, By Drug Type, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Tafamidis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diflunisal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Inotersen
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Patisiran
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Tolcapone
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
U.S. Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Competitive Landscape
- Alnylam Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Prothena Corporation Plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ionis Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- SOM Innovation Biotech, S.L.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eidos Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BridgeBio Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Acrotech Biopharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Attralus, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 28 market data tables and 24 figures on 'Transthyretin Amyloidosis Treatment Market' – U.S. forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now